Desisobutyryl-ciclesonide is primarily used as an anti-inflammatory agent in the treatment of respiratory conditions such as asthma and allergic rhinitis. It works by reducing inflammation in the airways, which helps to alleviate symptoms like wheezing, shortness of breath, and nasal congestion. The compound is often administered via inhalation, allowing it to act directly on the lungs for more effective relief. It is also known for its localized action, minimizing systemic side effects compared to other corticosteroids. Additionally, it is sometimes prescribed for managing chronic obstructive pulmonary disease (COPD) to improve lung function and reduce flare-ups. Its efficacy and safety profile make it a preferred choice for long-term management of these conditions.